膝下旁路无同侧大隐静脉时的替代静脉导管选择
该研究分析1998年至2018年间在学术三级转诊中心使用对侧大隐静脉、小隐静脉或手臂静脉作为膝下旁路主要移植物的连续患者。结论认为三种替代静脉结局相当,血管外科医生应考虑所有自体选项。
要点
- 对侧大隐静脉、小隐静脉和手臂静脉均可作为膝下旁路的替代自体静脉。
- 三种替代静脉的5年通畅率、保肢率和生存率无显著差异。
- 当首选同侧大隐静脉不可用时,应考虑所有自体静脉选项。
核心结论
- 三种替代自体静脉(对侧大隐静脉、小隐静脉、手臂静脉)在膝下旁路结局参数上相当。
- 血管外科医生在首选静脉不可用时应考虑所有自体选项。
研究设计与样本
- 回顾性分析1998年1月至2018年7月在学术三级转诊中心连续使用对侧大隐静脉、小隐静脉或手臂静脉作为主要外周旁路移植物的患者。
- 共644例旁路手术使用替代静脉:对侧大隐静脉186例(28.9%),小隐静脉101例(15.7%),手臂静脉357例(55.4%)。
- 中位随访2.3年(范围9天至18.5年)。
临床怎么用
- 在膝下旁路手术中,若同侧大隐静脉不可用,可考虑对侧大隐静脉、小隐静脉或手臂静脉作为替代自体静脉。
- 三种替代静脉的结局相当,选择时可基于患者具体情况和静脉可用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Vein is regarded superior to artificial graft in peripheral arterial bypass surgery. However, this option is often limited owing to previous use or removal of the ipsilateral greater saphenous vein (iGSV). In this case, the contralateral great saphenous vein (cGSV), the small saphenous vein (SSV), or arm veins (AV) are possible alternatives. Experience with all three grafts for below knee vein bypass is reported. METHODS: Consecutive patients treated at an academic tertiary referral centre between January 1998 and July 2018 using the cGSV, SSV, or AV as the main peripheral bypass graft were analysed. Study end points were primary patency, secondary patency, limb salvage, and survival. RESULTS: Over the observed time period, 2642 bypass operations for treatment of peripheral artery disease with below knee target arteries were performed at the authors' institution: 1937 procedures using the iGSV; 644 bypass procedures using the cGSV (n = 186; 28.9%), SSV (n = 101; 15.7%), or AV (n = 357; 55.4%); and 61 procedures using a prosthetic graft. The median follow up period was 2.3 years (range 9 days-18.5 years). Thirty day mortality was 1.9% for the whole group and similar between the three groups. After five years, primary and secondary patency rates were comparable between the three groups. Secondary patency was 75% (95% confidence interval [CI] 66-83) in the cGSV and SSV groups, and 65% (95% CI 57-73) in the AV group (p = .47). Limb salvage and survival after five years were, respectively, 73% (95% CI 65-81) and 89% (95% CI 82-95) in the cGSV group, 79% (95% CI 69-89) and 87% (95% CI 79-95) in the SSV group, and 74% (95% CI 68-80) and 83% (77-89) in the AV group (p = .46). CONCLUSION: All three types of alternative autologous vein graft are equal regarding outcome parameters. Vascular surgeons should consider all autologous options if their preferred choice is not available.
引用
- Nierlich P, Enzmann FK, Metzger P, et al. Alternative Venous Conduits for Below Knee Bypass in the Absence of Ipsilateral Great Saphenous Vein. Eur J Vasc Endovasc Surg. 2020. PMID: 32768278. doi:10.1016/j.ejvs.2020.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。